Wearable sensor

- Biolinq Incorporated
Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description

FIG. 1 is a front perspective view of a wearable sensor showing the new design;

FIG. 2 is a front view thereof;

FIG. 3 is a top plan view thereof;

FIG. 4 is a bottom plan view thereof;

FIG. 5 is a left side view thereof;

FIG. 6 is a right side view thereof;

FIG. 7 is a rear view thereof;

FIG. 8 is a front perspective view of another wearable sensor showing the new design;

FIG. 9 is a front view thereof;

FIG. 10 is a top plan view thereof;

FIG. 11 is a bottom plan view thereof;

FIG. 12 is a left side view thereof;

FIG. 13 is a right side view thereof;

FIG. 14 is a rear view thereof;

FIG. 15 is a front perspective view of another wearable sensor showing the new design;

FIG. 16 is a front view thereof;

FIG. 17 is a top plan view thereof;

FIG. 18 is a bottom plan view thereof;

FIG. 19 is a left side view thereof;

FIG. 20 is a right side view thereof;

FIG. 21 is a rear view thereof;

FIG. 22 is a front perspective view of another wearable sensor showing the new design;

FIG. 23 is a front view thereof;

FIG. 24 is a top plan view thereof;

FIG. 25 is a bottom plan view thereof;

FIG. 26 is a left side view thereof;

FIG. 27 is a right side view thereof;

FIG. 28 is a rear view thereof;

FIG. 29 is a front perspective view of another wearable sensor showing the new design;

FIG. 30 is a front view thereof;

FIG. 31 is a top plan view thereof;

FIG. 32 is a bottom plan view thereof;

FIG. 33 is a left side view thereof;

FIG. 34 is a right side view thereof;

FIG. 35 is a rear view thereof;

FIG. 36 is a front perspective view of another wearable sensor showing the new design;

FIG. 37 is a front view thereof;

FIG. 38 is a top plan view thereof;

FIG. 39 is a bottom plan view thereof;

FIG. 40 is a left side view thereof;

FIG. 41 is a right side view thereof;

FIG. 42 is a rear view thereof;

FIG. 43 is a front perspective view of another wearable sensor showing the new design;

FIG. 44 is a front view thereof;

FIG. 45 is a top plan view thereof;

FIG. 46 is a bottom plan view thereof;

FIG. 47 is a left side view thereof;

FIG. 48 is a right side view thereof; and,

FIG. 49 is a rear view thereof.

The broken lines are for the purpose of illustrating portions of the article and form no part of the claimed design.

Claims

The ornamental design for a wearable sensor, as shown and described.

Referenced Cited
U.S. Patent Documents
4305401 December 15, 1981 Reissmueller et al.
4323996 April 6, 1982 Ganter
4407295 October 4, 1983 Steuer et al.
5131390 July 21, 1992 Sakaguchi
5279543 January 18, 1994 Glikfeld et al.
5286364 February 15, 1994 Yacynych et al.
5540828 July 30, 1996 Yacynych
5730714 March 24, 1998 Guy et al.
5766132 June 16, 1998 Yasukawa et al.
6036055 March 14, 2000 Mogadam et al.
6139718 October 31, 2000 Kurnik et al.
6269053 July 31, 2001 Kawata et al.
6284126 September 4, 2001 Kurnik et al.
6413396 July 2, 2002 Yang et al.
6471903 October 29, 2002 Sherman et al.
6603987 August 5, 2003 Whitson
6814845 November 9, 2004 Wilson et al.
6862466 March 1, 2005 Ackerman
6908453 June 21, 2005 Fleming
7097776 August 29, 2006 Govinda Raju
7132054 November 7, 2006 Kravitz et al.
7262068 August 28, 2007 Roy et al.
7343188 March 11, 2008 Sohrab
7344499 March 18, 2008 Prausnitz et al.
7429333 September 30, 2008 Chiou et al.
7456112 November 25, 2008 Lee
7493232 February 17, 2009 Surina
8022292 September 20, 2011 Arianpour et al.
8088321 January 3, 2012 Ferguson et al.
8094009 January 10, 2012 Allen et al.
8125331 February 28, 2012 Allen et al.
8130095 March 6, 2012 Allen et al.
8284046 October 9, 2012 Allen et al.
8574165 November 5, 2013 Marsh
8798799 August 5, 2014 Deo et al.
8909543 December 9, 2014 Tropper et al.
D722697 February 17, 2015 Moon et al.
D750786 March 1, 2016 Davies et al.
D757000 May 24, 2016 Lagomarsino et al.
9551698 January 24, 2017 Huys et al.
9737247 August 22, 2017 Wang et al.
9743870 August 29, 2017 Wang et al.
D815289 April 10, 2018 Evers et al.
D816229 April 24, 2018 Frick et al.
9933387 April 3, 2018 McCanna et al.
D820988 June 19, 2018 Pushpala
10092207 October 9, 2018 Windmiller
10136846 November 27, 2018 Wang et al.
D842996 March 12, 2019 Frick et al.
D845289 April 9, 2019 Chuang
10251565 April 9, 2019 Chan
D867911 November 26, 2019 Alabdin
10492708 December 3, 2019 Windmiller
D875254 February 11, 2020 Cooke
D882432 April 28, 2020 Yee
10765369 September 8, 2020 Antonio
11045142 June 29, 2021 Windmiller et al.
11207025 December 28, 2021 Trapero Martin
11406818 August 9, 2022 Windmiller
11654270 May 23, 2023 Mansfield et al.
11660392 May 30, 2023 Kamen
20030225360 December 4, 2003 Eppstein
20060015061 January 19, 2006 Kuo et al.
20070170054 July 26, 2007 Wilsey
20070213044 September 13, 2007 Steingart et al.
20090088652 April 2, 2009 Tremblay
20090143761 June 4, 2009 Cantor
20090259118 October 15, 2009 Feldman et al.
20100056873 March 4, 2010 Allen et al.
20100286803 November 11, 2010 Tillotson et al.
20120323097 December 20, 2012 Chowdhury
20130065257 March 14, 2013 Wang et al.
20130144131 June 6, 2013 Wang et al.
20140259652 September 18, 2014 Pushpala et al.
20140275897 September 18, 2014 Pushpala
20140336487 November 13, 2014 Wang et al.
20150335272 November 26, 2015 Natale et al.
20170055851 March 2, 2017 Al-Ali
20180249937 September 6, 2018 Wiese et al.
20190095602 March 28, 2019 Setlak et al.
20190125223 May 2, 2019 Wang et al.
20190167167 June 6, 2019 Mitchell et al.
20190309433 October 10, 2019 Sattayasamitsathit et al.
20200085341 March 19, 2020 Windmiller
20200101286 April 2, 2020 Windmiller et al.
20200214566 July 9, 2020 Allen et al.
20200254240 August 13, 2020 Windmiller et al.
20200297997 September 24, 2020 Windmiller et al.
20210187286 June 24, 2021 Windmiller et al.
20210393201 December 23, 2021 Morelock et al.
20220031209 February 3, 2022 Windmiller et al.
20220031244 February 3, 2022 Windmiller et al.
20220175278 June 9, 2022 Campbell et al.
20220370011 November 24, 2022 Windmiller et al.
20230074798 March 9, 2023 Tangney
20230094419 March 30, 2023 Mansfield, III et al.
20230099617 March 30, 2023 Mansfield, III et al.
20230137258 May 4, 2023 Windmiller
Foreign Patent Documents
717520 December 2021 CH
3871602 September 2021 EP
3042872 December 2020 FR
1721016 July 2022 JP
WO-2009034313 March 2009 WO
WO-2009064164 May 2009 WO
WO-2010120364 October 2010 WO
WO-2012020332 February 2012 WO
WO-2013058879 April 2013 WO
WO-2020073060 April 2020 WO
WO-2021148596 July 2021 WO
WO-2023055755 April 2023 WO
WO-2023064877 April 2023 WO
Other references
  • Abbot press release (2020). “New late-breaking data show use of Abbott's Freestyle® Libre System significantly reduces HBA1C levels in people with type 2 diabetes using insulin or not,” 3 pages.
  • American Diabetes Association® Press Release (2020). “American Diabetes Association ® Applauds policymakers' Focus on Addressing High Costs of Insulin for Seven Million Americans,” 4 pages.
  • Bantle, J.P. et al. (1997). “Glucose measurement in patients with diabetes mellitus with dermal interstitial fluid,” J. Lab. Clin. Med. 130:436-441.
  • Beckles, G.L. et al. (2016). “Disparities in the prevalence of diagnosed diabetes—United States, 1999-2002 and 2011-2014,” MMWR 65:1265-1269.
  • Biolinq, Inc. (2019). The Intelligent Continuous Glucose Monitoring System, 5 total pages.
  • Cao, J. et al. (2017). “Validation of capillary blood analysis and capillary testing mode on the epoc Point of Care system,” Pract. Lab. Med. 9:24-27.
  • Castle, J.R. et al. (2012). “The accuracy benefit of multiple amperometric glucose sensors in people with type 1 diabetes,” Diabetes Care 35:706-710.
  • Dexcom (2020). Analyst Day Presentation, 19 total pages.
  • Dexcom (2020). Analyst Day Presentation, 27 total pages.
  • Diabetes Care (2021). “7. Diabetes Technology: Standards of Medical Care in Diabetes—2021,” Diabetes Care 44(Supplement 1):S85-S99.
  • Fang, M. et al. (2021). “Trends in Diabetes Treatment and Control in U.S. Adults, 1999-2018,” N. Engl. Med. 384:2219-2228.
  • French, D.P. et al. (2008). “Original Article: Psychological Care Self-monitoring of blood glucose changed non-insulin-treated Type 2 diabetes patients' beliefs about diabetes and self-monitoring in a randomized trial,” Diav. Med. 25:1218-1228.
  • Grady, M. et al. (2017). “Examining the Impact of a Novel Blood Glucose Monitor with Color Range Indicator on Decision-Making in Patients With Type 1 and Type 2 Diabetes and its Association With Patient Numeracy Level,” JMIR Diabetes 2:e24.
  • Grady, M. et al. (2018). “Use of Blood Glucose Meters Featuring Color Range Indicators Improves Glycemic Control in Patients with Diabetes in Comparison to Blood Glucose Meters Without Color (Accents Study),” J. Diab. Sci. Tech. 12:1211-1219.
  • Groenendaal, W. et al. (2008). “Modeling Glucose and Water Dynamics in Human Skin,” Diab. Tech. Therap. 10:283-293.
  • Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group (2008). “Continuous Glucose Monitoring and Intensive Treatment of Type 1 Diabetes,” N. Engl. Med. 359:1464-1476.
  • Karter, A.J. et al. (2021). “Association of Real-time Continuous Glucose Monitoring With Glycemic Control and Acute Metabolic Events Among Patients With Insulin—Treated Diabetes,” JAMA 325:2273-2284.
  • Martens, T. et al. (2021). “Effect of Continuous Glucose Monitoring on Glycemic Control in Patients with Type 2 Diabetes Treated with Basal Insulin A Randomized Clinical Trial,” JAMA 325:2262-2272.
  • McClatchey, P.M. et al. (2019). “Fibrotic Encapsulation Is the Dominant Source of Continuous Glucose Monitor Delays,” Diabetes 68:1892-1901.
  • Neerken, S. et al. (2004). “Characterization of age-related effects in human skin: A comparative study that applies confocal laser scanning microscopy and optical coherence tomography,” J. Biomed. Optics 9:274-281.
  • Non-Final Office Action dated Nov. 14, 2019, for U.S. Appl. No. 29/650,794, filed Jun. 8, 2018, 10 pages.
  • Notice of Allowance dated Sep. 29, 2022, for U.S. Appl. No. 29/774,399, filed Mar. 16, 2021, 7 pages.
  • Notice of Allowance dated Jan. 25, 2023, for U.S. Appl. No. 29/774,399, filed Mar. 16, 2021, 11 pages.
  • Notice of Allowance dated Dec. 18, 2019, for U.S. Appl. No. 29/650,794, filed Jun. 8, 2018, 7 pages.
  • Notice of Allowance dated May 17, 2023, for U.S. Appl. No. 29/836,984, filed Apr. 29, 2022, 7 pages.
  • Polonsky, W.H. et al. (2011). “A survey of blood glucose monitoring in patients with type 2 diabetes: Are recommendations from health care professionals being followed?” Curr. Med. Res. & Opinion 27:31-37.
  • Rigla, M. et al. (2018). “Human Subcutaneous Tissue Response to Glucose Sensors: Macrophages Accumulation Impact on Sensor Accuracy,” Diabetes Technology & Therapeutics 20:296-302.
  • Sheikh, Z. et al. (2015). “Macrophages, Foreign Body Giant Cells and Their Response to Implantable Biomaterials,” Materials 8:5671-5701.
  • Shi, T. et al. (2016). “Modeling and Measurement of Correlation between Blood and Interstitial Glucose Changes,” J. Diab. Res. vol. 2016, 9 pages.
  • Al Hayek et al., “Patient Satisfaction and Clinical Efficacy of Novel Blood Glucose Meters Featuring Color Range Indicators in Patients With Type 2 Diabetes: A Prospective Study” Cureus Oct. 27, 2020; 12(10):e11195. doi: 10.7759/cureus.11195.
  • Allen et al., “Continuous glucose monitoring counseling improves physical activity behaviors of individuals with type 2 diabetes: A randomized clinical trial” Diabetes Res Clin Pract. Jun. 2008 80(3): 371-379. doi:10.1016/j.diabres.2008.01.006.
  • Barrett et al., “Risk for Newly Diagnosed Diabetes >30 Days After SARS-CoV-2 Infection Among Persons Aged <18 Years—United States, Mar. 1, 2020-Jun. 28, 2021” MMWR Morb Mortal Wkly Rep. Jan. 14, 2022; 71(2):59-65. doi: 10.15585/mmwr.mm7102e2.
  • Centers for Disease Control, “National Diabetes Statistics Report 2020 Estimates of Diabetes and Its Burden in the United States” (2020) 32 pages.
  • Dunkin et al., “Scarring occurs at a critical depth of skin injury: precise measurement in a graduated dermal scratch in human volunteers” Plast Reconstr Surg. May 2007; 119(6):1722-1732. doi: 10.1097/01.prs.0000258829.07399.f0.
  • Ehrhardt et al, “The Effect of Real-Time Continuous Glucose Monitoring on Glycemic Control in Patients with Type 2 Diabetes Mellitus” Journal of Diabetes Science and Technology May 2011; 5(3):668-675.
  • Ehrhardt et al, “Behavior Modification in Prediabetes and Diabetes: Potential Use of Real-Time Continuous Glucose Monitoring ” Journal of Diabetes Science and Technology Mar. 2019; 13(2):271-275.
  • Ehrhardt et al, “Continuous Glucose Monitoring As a Behavior Modification Tool” Clin Diabetes. Apr. 2020; 38(2):126-131. doi: 10.2337/cd19-0037.
  • Fonda et al., “The Cost-Effectiveness of Real-Time Continuous Glucose Monitoring (RT-CGM) in Type 2 Diabetes” Journal of Diabetes Science and Technology (2016) 10(4):898-904.
  • Han et al., “The End of the Road for the YSI 2300 Analyzer: Where Do We Go Now?” Journal of Diabetes Science and Technology (2020) 14(3):595-600.
  • Han et al., “The YSI 2300 Analyzer Replacement Meeting Report” Journal of Diabetes Science and Technology (2020) 14(3):679-686.
  • Sharifi et al., “Redundancy in Glucose Sensing: Enhanced Accuracy and Reliability of an Electrochemical Redundant Sensor for Continuous Glucose Monitoring” Journal of Diabetes Science and Technology (2016) 10(3):669-678.
  • Turner et al., “Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)” The Lancet Sep. 1998; 352(9131):837-853.
  • Vigersky et al., “Short- and Long-Term Effects of Real-Time Continuous Glucose Monitoring in Patients with Type 2 Diabetes” Diabetes Care Jan. 2012; 35:32-38.
  • Wolicki et al., “Epidemiology and Prevention of Vaccine-Preventable Diseases: Chapter 6: Vaccine Administration” Centers for Disease Control and Prevention (2021) 17 pages.
  • World Health Organization, “Diabetes”, Sep. 16, 2022, 5 pages.
  • Young et al., “Glucose Self-monitoring in Non-Insulin-Treated Patients With Type 2 Diabetes in Primary Care Settings: A Randomized Trial” JAMA Intern Med. Jul. 2017; 177(7):920-929.
Patent History
Patent number: D996999
Type: Grant
Filed: Nov 16, 2021
Date of Patent: Aug 29, 2023
Assignee: Biolinq Incorporated (San Diego, CA)
Inventor: David Michael Morelock (Escondido, CA)
Primary Examiner: Antoine Duval Davis
Application Number: 29/815,797